Literature DB >> 31055609

Fluoroscopic guided tunnel placement during medial patellofemoral ligament reconstruction is not accurate in patients with severe trochlear dysplasia.

Kaywan Izadpanah1, Hans Meine2,3, Johanna Kubosch4, Gernot Lang4, Andreas Fuchs4, Dirk Maier4, Peter Ogon4,5, Norbert P Südkamp4, Matthias J Feucht4,6.   

Abstract

PURPOSE: Accurate femoral tunnel placement is of great importance during medial patellofemoral ligament (MPFL) reconstruction. Purpose of the present study was to investigate the influence of trochlear dysplasia on the accuracy of fluoroscopic guided femoral tunnel placement.
METHODS: CT-Scans of 30 knees (five with regular shaped trochlea, 10 with a Type A and five each with a Type B, C, or D trochlear dysplasia) were imported into the image analysis platform MeVisLab. A 3D Bone Volume Rendering (VR) and a virtual lateral radiograph was created. The anatomic femoral MPFL insertion was identified on the 3D VR. On virtual lateral radiographs, the MPFL insertion was identified based on landmarks described by Schöttle et al. using three different perspectives: Best possible overlap of the femoral condyles (BC) and a tangent along posterior border of the posterior femoral cortex (pBC); a tangent along the anterior border of the posterior cortex (aBC); and best possible overlap of the distal part of the posterior femoral cortex (BF). Distances between the anatomic attachment and radiographically obtained insertions were measured on the 3D VR and compared according to the type of trochlear dysplasia.
RESULTS: Significantly lower accuracy of fluoroscopy guided tunnel placement in MPFL reconstruction was found in knees with Type C and D dysplasia. This effect was observed irrespectively from the radiologic perspective (pBC, aBC, and FC). In the pBC view (highest accuracy), the mean distance from the centre of the anatomic MPFL attachment to the radiographically defined location was 4.3 mm in knees without trochlear dysplasia and increased to 4.8 mm in knees with Type A dysplasia, 3.8 mm in knees with Type B dysplasia, 6.7 mm (p < 0.001) in knees with Type C dysplasia, and 7.3 mm (p < 0.001) in knees with Type D dysplasia.
CONCLUSION: Radiographic landmark-based femoral tunnel placement in the pBC view provides highest accuracy in knees with a normal shaped trochlea or low grade trochlear dysplasia. In patients with severe dysplasia, fluoroscopy guided tunnel placement has a low accuracy, exceeding a critical threshold of 5 mm distance to the anatomic MPFL insertion irrespective of the radiographic perspective. In these patients, utilization of anatomic landmarks may be beneficial. LEVEL OF EVIDENCE: IV.

Entities:  

Mesh:

Year:  2019        PMID: 31055609     DOI: 10.1007/s00167-019-05413-6

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  4 in total

Review 1.  [Research progress in femoral tunnel positioning points of medial patellofemoral ligament reconstruction].

Authors:  Yan Zhang; Yanlin Li; Dejian Liu; Guoliang Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-02-15

2.  Failure Analysis in Patients With Patellar Redislocation After Primary Isolated Medial Patellofemoral Ligament Reconstruction.

Authors:  Matthias J Feucht; Julian Mehl; Philipp Forkel; Andrea Achtnich; Andreas Schmitt; Kaywan Izadpanah; Andreas B Imhoff; Daniel P Berthold
Journal:  Orthop J Sports Med       Date:  2020-06-22

Review 3.  Medial patellofemoral ligament reconstruction: A review.

Authors:  Yong-Qiang Zhang; Zhao Zhang; Meng Wu; Ya-Dong Zhou; Sheng-Lin Tao; Ya-Long Yang; Yang Li; Jun-Liang Liu; Peng Li; Yun-Sheng Teng; Yong-Ming Guo
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

4.  Computed Tomography Imaging Analysis of the MPFL Femoral Footprint Morphology and the Saddle Sulcus: Evaluation of 1094 Knees.

Authors:  Jiebo Chen; Yijia Xiong; Kang Han; Caiqi Xu; Jiangyu Cai; Chenliang Wu; Zipeng Ye; Jinzhong Zhao; Guoming Xie
Journal:  Orthop J Sports Med       Date:  2022-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.